Authors:
Bracho, F
Krailo, MD
Shen, V
Bergeron, S
Davenport, V
Liu-Mares, W
Blazar, BR
Panoskaltsis-Mortari, A
van de Ven, C
Secola, R
Ames, MM
Reid, JM
Reaman, GH
Cairo, MS
Citation: F. Bracho et al., A phase I clinical, pharmacological, and biological trial of interleukin 6plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutionaltoxicities, CLIN CANC R, 7(1), 2001, pp. 58-67
Authors:
Goldman, SC
Bracho, F
Davenport, V
Slack, R
Areman, E
Shen, V
Lenarsky, C
Weinthal, J
Hughes, R
Cairo, MS
Citation: Sc. Goldman et al., Feasibility study of IL-11 and granulocyte colony-stimulating factor aftermyelosuppressive chemotherapy to mobilize peripheral blood stem cells fromheavily pretreated patients, J PED H ONC, 23(5), 2001, pp. 300-305
Authors:
Houtenbos, I
Bracho, F
Davenport, V
Slack, R
van de Ven, C
Suen, Y
Killen, R
Shen, V
Cairo, MS
Citation: I. Houtenbos et al., Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC), BONE MAR TR, 27(2), 2001, pp. 145-153
Authors:
Davenport, V
Morris, JF
Motazed, R
Chu, AC
Citation: V. Davenport et al., p53 induction in normal human skin in vitro following exposure to solar simulated UV and UV-B irradiation, J PHOTOCH B, 49(2-3), 1999, pp. 177-186